Related Experiment Videos
An approach to vaccines against human immunodeficiency virus
M Girard1, F Barré-Sinoussi, E Van Der Ryst
1Institut Pasteur, Paris, France.
AIDS Research and Human Retroviruses
|March 20, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Highly prevalent Russian HIV-1 V3-loop sequence variants are susceptible to maraviroc.
Antiviral chemistry & chemotherapy·2021
Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?
Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2014
The innate immune response, clinical outcomes, and ex vivo HCV antiviral efficacy of a TLR7 agonist (PF-4878691).
Clinical pharmacology and therapeutics·2011
Trends in HIV/AIDS Knowledge and Self-Testing Preferences Among College Students: A Five-Year Repeated Cross-Sectional Survey in Shenzhen, China.
AIDS research and human retroviruses·2026
Efficacy and Safety of Albuvirtide Plus Dolutegravir or Dolutegravir/Lamivudine in Hospitalized People with Advanced AIDS: A Retrospective Real-World Study.
AIDS research and human retroviruses·2026
Genomic Characterization of Two Novel HIV-1 CRF01_AE/CRF07_BC Unique Recombinant Forms in Shenzhen, China.
AIDS research and human retroviruses·2026
Post-Traumatic Stress Symptoms Related to the COVID-19 Pandemic in Persons Living and Aging with HIV.
AIDS research and human retroviruses·2026
Sequence Notes: Identification of a Novel HIV-1 Circulating Recombinant Form (CRF200_0755) in a Southern Border Region of Yunnan, China.
AIDS research and human retroviruses·2026
Fluctuating Immune Reconstitution and Delayed HIV-1 DNA Decline in People Living with HIV with Low CD4 on Bictegravir-Based Therapy.
AIDS research and human retroviruses·2026